Dose Can Help to Achieve Effective Pain Relief for Acute Mild to Moderate Pain with Over-the-Counter Paracetamol
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Paracetamol (acetaminophen) is one of the most widely used Over-The-Counter (OTC) analgesics for the self-treatment of mild to moderate acute pain. Different dosages are used in different countries and, in some of them, a large proportion of adults are using low doses (325 mg to 500 mg). Objectives: The objective of the study was to review information from published research studies to answer the question: is there a dose-dependent analgesic effect of paracetamol in the treatment of mild to moderate acute pain? Methods: A detailed assessment of available systematic reviews, meta-analyses and single randomised trials was undertaken based on an electronic literature search focusing on studies comparing higher and lower doses of paracetamol in the management of mild to moderate acute pain. Results: Reviews and comparative trials generally showed greater efficacy with higher dose paracetamol (1000 mg) than with lower doses (500 mg or 650 mg) in achieving clinically significant pain relief with comparable tolerability in different types of pain. Conclusions: The nature and intensity of the pain are two key elements of the therapeutic choice. Higher dose immediate-release paracetamol (1000 mg), used for a short duration of time (4-5 days) and adhering to recommendations within the label for risk groups, delivers safe and more effective analgesia than lower doses for adults with mild to moderate acute pain. Strengths and Limitations of this Study: • Paracetamol is one of the most widely used OTC analgesics for the self- treatment of mild to moderate acute pain and this study aims to explore the practical question of whether the use of low doses, which is common in some countries, provides suboptimal pain relief. • This review provides an overview of previous studies focusing on comparing the analgesic efficacy of different doses of paracetamol rather than comparing the effect of different OTC analgesics. • This review details a narrative assessment of available systematic reviews, meta-analysis and randomised trials but does not offer a quantitative analysis of pain relief achieved with different doses of paracetamol. • The review does not provide an overview of studies focusing on different forms of paracetamol. • The focus for this review is immediate release paracetamol. Combined and slow release paracetamol formulations were not considered of relevance. The latter are in the process of being suspended across the European Union due to safety concerns with overdosing [1].
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both direct and indirect comparisons demonstrated analgesic superiority of higher single dose compared to lower single doses, highlighting that a higher single dose of paracetamol for a short duration (4–5 days) poses more benefit than lower single doses.80”
In the citing paper
“Thus, several guidelines recommend paracetamol as an optimal option for mild-to-moderate pain conditions, such as headache and migraine attacks, postoperative pain and chronic osteoarthritis for limited duration of treatment (however, with some discrepancies here, according to guidelines).78–81”
Citations
Cites
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796 · cited 1×
“Osteoarthritis Research Society International (OARSI) guidelines recommend the use of paracetamol (up to 4 g/day) as an effective initial oral analgesic for the treatment of mild to moderate pain in patients with knee or hip osteoarthritis [13].”
BackgroundZhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338 · cited 1×
“For osteoarthritis of the hand, the European League Against Rheumatism (EULAR) guidelines recommend paracetamol (up to 4g/day) as the oral analgesic of the first choice because of its efficacy and safety [14].”
BackgroundAcetaminophen-Induced Hepatotoxicity: a Comprehensive Update
(2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00052 · Cited by 744
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. C. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 632
Paracetamol: not as safe as we thought? A systematic literature review of observational studies
Roberts, E., Delgado Nunes, V., Buckner, S., Latchem, S., Constanti, M., Miller, P., Doherty, M., Zhang, W., Birrell, F., Porcheret, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206914 · Cited by 412
Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome
Moore, R. A., Straube, S., & Aldington, D. (2013) · Anaesthesia · doi:10.1111/anae.12148 · Cited by 362
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
Lipton, R. B., Fanning, K. M., Serrano, D., Reed, M. L., Cady, R., & Buse, D. C. (2015) · Neurology · doi:10.1212/wnl.0000000000001256 · Cited by 315
Single dose oral paracetamol (acetaminophen) for postoperative pain in adults
Toms, L., McQuay, H. J., Derry, S., & Moore, R. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004602.pub2 · Cited by 311 · cited 1×
“However, it has been suggested that dose-response may be more successfully assessed using trials directly comparing two doses [21], as evidenced in a recent review [19].”
BackgroundNon-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews
Moore, R. A., Wiffen, P. J., Derry, S., Maguire, T., Roy, Y. M., & Tyrrell, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010794.pub2 · Cited by 174 · cited 5×
“The previously mentioned Cochrane review of non-prescription oral analgesics for acute pain reported safety data for paracetamol 975/1000mg and for paracetamol 600/650mg [20].”
BackgroundMethodResultInfluentialLipton, R. B., Baggish, J. S., Stewart, W. F., Codispoti, J. R., & Fu, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3486 · Cited by 141
Research works printed but not linked: 4
- Canadian Agency for Drugs and Technologies in Health. Rapid Response Report: Summary with Critical Appraisal. 1000mg versus 600/650mg acetaminophen for pain or fever: A review of the clinical efficacy Available from: 2013. https://www.cadth.ca/sites/ default/files/pdf/htis/ june2016/RC0786%20Acetaminop hen%20Dose%20Final.pdf 17 June 2016.
- Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the rheumatic diseases 2007; 66 (3) : 377-88. · DOI · Paper page
- Schwarz ES, Delgado Nunes Mullins ME. Paracetamol: Is all the concern valid?. Ann Rheum Dis 2015; 75 (3) : 552-9. · doi:10.1136/annrheumdis-2015-206914
- Caparrotta TM, Antoine DJ, Dear JW. paracetamol-induced liver injury? A critical review of the literature. Eur J Clin Pharmacol 2017; 1-4.
Cited by
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Both direct and indirect comparisons demonstrated analgesic superiority of higher single dose compared to lower single doses, highlighting that a higher single dose of paracetamol for a short duration (4–5 days) poses more benefit than lower single doses.(80) This observation is consistent with the successful experime…”
ResultSelf-citationTreatments for Acute Pain: A Systematic Review
Chou, R., Wagner, J., Ahmed, A. Y., Blazina, I., Brodt, E., Buckley, D., Cheney, T. P., Choo, E. K., Dana, T., Gordon, D. A., et al. (2020) · doi:10.23970/ahrqepccer240 · Cited by 87
Alchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Perrot, S., Eschalier, A., Desmeules, J., Lanteri-Minet, M., & Attal, N. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2076475 · Cited by 6
Self-citationZakharova, I. N., Berezhnaya, I. V., Pupykina, V. V., Gostyukhina, A. D., & Dubovets, N. F. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-367 · Cited by 4
Metadata
- Authors
- Gaul, C., & Eschalier, A.
- Affiliations
- Migräne Klinik Königstein (DE)
- Inserm (FR)
- Corresponding author
- Gaul, Charly
- Venue
- The Open Pain Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-09-28
- Volume
- 11
- Issue
- 1
- Pages
- 12-20
- ISSN
- 1876-3863 (ISSN-L)
- OpenAlex
- W2890132167
- Cited by
- 8
- References
- 25
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2022: 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- The Open Pain Journal (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- paracetamol, acute pain, over-the-counter analgesics, analgesic efficacy, tolerability, self-medication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dose Can Help to Achieve Effective Pain Relief for Acute Mild to Moderate Pain with Over-the-Counter Paracetamol. https://app.cochat.ai/papers/10.2174/1876386301811010012
- The paper
- Gaul, C., & Eschalier, A. (2018). Dose Can Help to Achieve Effective Pain Relief for Acute Mild to Moderate Pain with Over-the-Counter Paracetamol. The Open Pain Journal. https://doi.org/10.2174/1876386301811010012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.